Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: Am J Perinatol. 2020 Dec 15;38(7):649–656. doi: 10.1055/s-0040-1721697

Table 3.

Outcomes of overall cohort and groups by development of SFGR

All discordant MCDA twins (n = 70) By development of SFGRa
SFGR present (n = 19) SFGR absent (n = 15) p-Value
Pregnancy outcomeb
 Good (dual delivery ≥ 30.0 wk) 53 (73%) 17 (89%) 10 (67%) 0.10
 Mixed (single loss or delivery 26.0–29.9 wk) 17 (23%) 2 (11%) 5 (33%)
 Poor (dual loss or delivery < 26.0 wk) 3 (4%) 0 0
GA at delivery, wk 33 (30.4–35.0) 34 (32.3–35.3) 32 (27.6–34.9) 0.19
BW discordance, % 28 (20.1–35.1) 29 (22.2–43.8) 23 (13.4–30.2) 0.12
Latency from ITWD to delivery, d 81 (60–102) 88 (67–109) 78 (47–101) 0.18
Latency from SFGR to deliveryc, d 38 (7–65) - - -
Latency from AREDF to deliveryd, d 51 (40–78) - - -

Abbreviations: AREDF, absent or reversed end-diastolic flow; BW, birth weight; GA, gestational age; ITWD, intertwin weight discordance; MCDA, monochorionic, diamniotic; SFGR, selective fetal growth restriction.

Note: Continuous variables presented as median (interquartile range) and categorical variables as n (%).

a

n = 34 for this analysis due to inclusion of only those with adequate UCSF ultrasound follow-up to assess for development of SFGR (defined as last UCSF ultrasound within 4 weeks of delivery).

b

For this primary outcome, all n = 73 discordant MCDA twins were included. The remaining outcomes included n = 70, excluding the 3 who opted for termination of pregnancy following spontaneous intrauterine fetal demise of one twin.

c

Latency among the n = 19 who developed SFGR.

d

Latency among the n = 32 who developed AREDF